 |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05903482 |
|
Recruitment Status : **RECRUITING NOW**
First Posted : June 14, 2023 Last Update Posted : June 14, 2023 |
Sponsor:
Information provided by (Responsible Party):
Elaina Lin, Children’s Hospital of Philadelphia
Brief Summary:
Evaluating gastric volume in patients on GLP-1 RA medications
| Diabetes | Other: None – observational |
| Study Type : | Observational |
| Estimated Enrollment : | 90 participants |
| Observational Model: | Cohort |
| Time Perspective: | Cross-Sectional |
| Official Title: | Gastric Volume in Patients on GLP-1 Medications |
| Actual Study Start Date : | June 6, 2023 |
| Estimated Primary Completion Date : | December 31, 2023 |
| Estimated Study Completion Date : | December 31, 2023 |
| Diabetic, in GLP-1 RA | Other: None – observational
Observational |
| Diabetic, not on GLP-1 RA | Other: None – observational
Observational |
| Non-diabetic, not on GLP-1 RA | Other: None – observational
Observational |
- Gastric volume in pediatric patients on GLP-1 RA [ Time Frame: single observation ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study:  | up to 18 Years  (Child, Adult) |
| Sexes Eligible for Study: Â | All |
| Accepts Healthy Volunteers: Â | No |
| Sampling Method: Â | Probability Sample |
Fasting children on GLP-1 RA
Inclusion Criteria:
Fasting Diabetic On GLP-1 RA
Exclusion Criteria:
Prior surgery that affects gastric anatomy
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05903482
| Contact: Elaina Lin | 2674265366 | line1@chop.edu |
| Children’s Hospital of Philadelphia | |
| Philadelphia, Pennsylvania, United States, 19004 | |
| Contact: Elaina Lin   267-426-5366   line1@chop.edu   | |
Children’s Hospital of Philadelphia
| Responsible Party: | Elaina Lin, Attending Physician, Children’s Hospital of Philadelphia |
| ClinicalTrials.gov Identifier: | NCT05903482 Â Â |
| Other Study ID Numbers: | 23-021125 |
| First Posted: | June 14, 2023 Â Â Key Record Dates |
| Last Update Posted: | June 14, 2023 |
| Last Verified: | June 2023 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
